Medicine for the Material World
ABSTRACT It is clear that many of the inorganic materials of antiquity have been used both as medicines for human ills and also as agents in technological processes. This paper speculates that there might have been a stronger link between these two functions in the past, based on the concept of “active agents”—materials that are efficacious at curing ...
A. M. Pollard
wiley +1 more source
Improvements, Challenges, and the Investigation of Two Unknowns in Arsenic Urine Speciation Analysis by HPLC-ICP-MS: From Development to Post-implementation. [PDF]
Smith K +3 more
europepmc +1 more source
Retinal injury mouse model and pathophysiological assessment of the effect of arsenical vesicants. [PDF]
Zhylkibayev A +5 more
europepmc +1 more source
ABSTRACT In 1837, the Tyrolean State Museum Ferdinandeum in Innsbruck, Austria, purchased a Roman bronze statue of a maenad from the 2nd century ce with red garnets as facetted eye inlays found near Brixen, Southern Tyrol. These garnets were investigated using optical microscopy, a portable hand‐held and a stationary micro‐X‐ray fluorescence device, as
H. Albert Gilg +3 more
wiley +1 more source
Metabolic Signature of Arsenic Exposure and Metabolism: The Folic Acid and Creatine Trial. [PDF]
Li W +22 more
europepmc +1 more source
The relationship between the climate and societal transformation in Maya lowlands has long been debated, particularly the role of drought in shaping the civilization trajectory during the Classic Period. A high‐resolution, multi‐proxy, geochemical record from Lake Kaná, located in the underexplored Uaymil region of the Yucatán Peninsula in Mexico ...
Haydar B. Martinez‐Dyrzo +5 more
wiley +1 more source
Chronic kidney disease amplifies severe kidney injury and mortality in a mouse model of skin arsenical exposure. [PDF]
Srivastava RK +10 more
europepmc +1 more source
Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown +2 more
wiley +1 more source
Arsenic efflux mechanisms in ectomycorrhizal mushrooms Hebeloma bulbiferum and Hebeloma sinapizans. [PDF]
Šnábl J +6 more
europepmc +1 more source
Arsenite Methyltransferase Diversity and Optimization of Methylation Efficiency. [PDF]
Chen J, Rosen BP.
europepmc +1 more source

